Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Prostate-Specific Antigen
  • Prostatic Neoplasms
  • Radiotherapy, Conformal

abstract

  • In addition to clinical stage and Gleason score, PSA-DT was a powerful predictor of DM among patients who develop an isolated PSA relapse after external-beam radiotherapy for prostate cancer. Patients who develop biochemical relapse with PSA-DT < or = 6 months should be considered for systemic therapy or experimental protocols because of the high propensity for rapid DM development.

publication date

  • December 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.02.111

PubMed ID

  • 15681527

Additional Document Info

start page

  • 826

end page

  • 31

volume

  • 23

number

  • 4